ArticleHarm reduction journal2026
"People are going to do drugs:" harm reduction as a strategy for survivors of sex trafficking who use substances.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurvivors of sex trafficking often experience co-occurring substance use and face significant barriers to accessing care. Harm reduction offers a nonjudgmental, survivor-centered approach to mitigating health risks associated with substance use and commercial sex. However, limited research has explored how harm reduction is understood and implemented by service providers working with this population. This study aimed to examine service providers' perspectives on the role, impact, and challenges of harm reduction in supporting survivors of sex trafficking who use substances.
methodsThis qualitative study employed purposive and snowball sampling to recruit 21 service providers from human trafficking, domestic violence, and other agencies across the southwestern US who serve survivors of sex trafficking. Semi-structured interviews were conducted to explore participants' experiences with harm reduction strategies, perceived barriers, and relational dynamics in service provision. Interviews were transcribed verbatim and analyzed using thematic analysis, following Braun and Clarke's six-step process. A constant comparative method was used to refine codes and identify emergent themes.
resultsFive major themes were identified: (1) comprehensive harm reduction as a lifesaving strategy, (2) education and health literacy as critical intervention tools, (3) navigating barriers to harm reduction, (4) relational foundations of harm reduction, and (5) ambivalence toward harm reduction as a standalone strategy. Participants described harm reduction as essential to preventing overdose, reducing disease transmission, and fostering engagement through nonjudgmental care. They emphasized the importance of peer-led outreach, trauma-informed education, and holistic support that includes meeting basic needs. However, providers also reported legal and institutional constraints, funding challenges, and public misconceptions that hindered implementation. A minority of participants expressed ambivalence about harm reduction, reflecting ongoing tensions between abstinence-based and non-abstinence approaches.
conclusionsHarm reduction is viewed by providers as a vital, relational, and flexible approach to supporting survivors of sex trafficking who use substances. Findings highlight the need for policy reform, increased investment in peer-led and trauma-informed models, and broader cultural shifts to reduce stigma. Future research should include survivor perspectives and explore harm reduction strategies across diverse geographic and demographic contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.